Apremilast in people living with HIV with psoriasis vulgaris: A case report | Zendy

BelaJ Shah | Zendy; Deval Mistry | Zendy; Navin Chaudhary | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Apremilast in people living with HIV with psoriasis vulgaris: A case report

Author(s) -

BelaJ Shah,

Deval Mistry,

Navin Chaudhary

Publication year - 2019

Publication title -

indian journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 36

eISSN - 1998-3611

pISSN - 0019-5154

DOI - 10.4103/ijd.ijd_633_18

Subject(s) - apremilast , psoriasis , medicine , dermatology , human immunodeficiency virus (hiv) , immunosuppression , immunology , psoriatic arthritis

Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until now, there have been no documented case of apremilast therapy for HIV-associated psoriasis in India. Here, we report a case of HIV-associated psoriasis who achieved Psoriasis Area and Severity Index (PASI) 100 with apremilast therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research